4
Changes in Ownership
Bambusa Therapeutics, Inc. Filed Acc 0001982614-26-000004
Director bought 375,000 shares at $16.00 ($6,000,000)
- Director acquired 4,769,701 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeggle Helmut Wolfgang Director | 2026-11-02 | Conversion | +4,769,701 | 8,889,301 | I | ||
| Jeggle Helmut Wolfgang Director | 2026-11-02 | Purchase | +375,000 | $16.00 | $6,000,000 | 9,264,301 | I |
| Derivatives | |||||||
| Jeggle Helmut Wolfgang Director | 2026-11-02 | Conversion · Series Seed Plus Preferred Stock | −3,135,066 | 0 | I | ||
| Jeggle Helmut Wolfgang Director | 2026-11-02 | Conversion · Series A-1 Preferred Stock | −1,473,775 | 0 | I | ||
| Jeggle Helmut Wolfgang Director | 2026-11-02 | Conversion · Series A-2 Preferred Stock | −160,860 | 0 | I | ||
| Open-market purchases · 375,000 sh · avg $16.00 · $6,000,000 | |||||||
Loading xslF345X06/form4-11022026_091105.xml…